ADVICENNE |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.97 EUR | +5.35% |
|
+15.75% | -25.94% |
| 04-08 | Advicenne S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 03-25 | Advicenne: ODD designation in cystinuria | CF |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ADVICENNE | Biopharmaceuticals | +5.35% | +15.75% | -25.94% | -47.04% | -79.52% | 24.85M |  |  | |
- Stock Market
- Equities
- ALDVI Stock
- Charts Advicenne
- Relative Strength Chart
